Be acknowledged as an active contributor in your field of expertise
- Discuss your findings and network with peers.
- Engage with fellow researchers, key opinion leaders, potential co-investigators and mentors in your field.
Give your work long-term visibility
- Be published in the European Heart Journal – Acute Cardiovascular Care, the online supplement
- Get visibility on ESC 365, the cardiology knowledge hub.
Competitions
Award competitions
Young Investigators Award - Selected for the outstanding quality of their work, young Investigators (aged under 40) are competing in front a jury during the Young Investigators Awards Session.
Research Prize - Member of the Acute Cardiovascular Care community? Submit your abstract under the Research Prize option. The session will be dedicated to unpublished research in acute cardiovascular care focusing on quality of care, clinical outcomes, or translational research applied to the development of novel therapeutic, diagnostic and logistical strategies to improve patient care and long-term outcomes.
Winners of the Award competitions will receive a prize of €1,500 along with an Association for Acute CardioVascular Care (ACVC) Silver Membership, and a complimentary printed copy of the Intensive and Acute Cardiac Care textbook.
All finalists will be offered a free registration to ESC Acute CardioVascular Care 2024.
Best paper Poster and Best Moderated ePoster Prizes
All abstracts accepted as paper Poster and Moderated ePoster will compete to receive a Best paper Poster / Best Moderated ePoster distinction.
All winners will be announced at the Closing Ceremony, held on Sunday, 10 March at 12:50.
Congress grants
This year again, ACVC will support the presentation of top-notch research by offering the registration for ESC CardioVascular Care Congress 2024 to 25 abstract and clinical case presenters around the world who have little or no access to funding or difficulties in obtaining financial assistance.
Grantees will be required to attend the congress onsite in Athens from 8 to 10 March 2024.
Our mission: To reduce the burden of cardiovascular disease.